• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367

Introduction to 3-(Pyrrolidine-1-sulfonyl)benzohydrazide (CAS No. 328028-06-4)

3-(Pyrrolidine-1-sulfonyl)benzohydrazide (CAS No. 328028-06-4) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its pyrrolidine-1-sulfonyl and benzohydrazide functional groups, exhibits unique chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules. The structural features of this compound contribute to its potential applications in drug discovery, particularly in the development of novel therapeutic agents targeting a range of diseases.

The pyrrolidine-1-sulfonyl moiety is a key structural element that imparts specific electronic and steric properties to the molecule. Pyrrolidine derivatives are well-known for their role in medicinal chemistry due to their ability to interact with biological targets such as enzymes and receptors. The sulfonyl group further enhances the compound's reactivity and binding affinity, making it an attractive scaffold for designing pharmacophores. In contrast, the benzohydrazide component introduces a hydrazine moiety, which is often involved in forming coordination complexes with metal ions and has been explored for its potential antimicrobial and anti-inflammatory properties.

Recent advancements in chemical biology have highlighted the importance of multifunctional compounds like 3-(Pyrrolidine-1-sulfonyl)benzohydrazide in addressing complex pathological conditions. The compound's dual functionality allows for versatile modifications, enabling researchers to fine-tune its pharmacological profile for specific therapeutic applications. For instance, studies have demonstrated that derivatives of this class can modulate enzyme activity by acting as competitive inhibitors or by participating in covalent bond formation with target proteins.

In the context of drug development, 3-(Pyrrolidine-1-sulfonyl)benzohydrazide has been investigated for its potential role in treating neurological disorders. The pyrrolidine scaffold is frequently found in drugs that target neurotransmitter systems, suggesting that this compound may exhibit effects on synaptic transmission or receptor modulation. Preliminary computational studies have indicated that it could interact with receptors involved in pain perception and cognitive function, making it a promising candidate for further exploration.

The synthesis of 3-(Pyrrolidine-1-sulfonyl)benzohydrazide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Key synthetic pathways often involve sulfonylation of pyrrolidine derivatives followed by hydrazination with benzohydrazide precursors. Advances in catalytic methods have improved the efficiency of these reactions, reducing the need for harsh reagents and minimizing waste generation. Such green chemistry approaches align with the growing emphasis on sustainable practices in pharmaceutical manufacturing.

From a medicinal chemistry perspective, the structural diversity offered by 3-(Pyrrolidine-1-sulfonyl)benzohydrazide allows for the exploration of various analogs with enhanced pharmacological properties. Researchers are increasingly leveraging structure-activity relationship (SAR) studies to optimize potency, selectivity, and bioavailability. The benzohydrazide moiety, in particular, provides a handle for further derivatization, enabling the creation of libraries of compounds for high-throughput screening.

The compound's potential extends beyond traditional drug development into areas such as materials science and agrochemicals. Its ability to form stable complexes with metal ions makes it useful in developing metal-organic frameworks (MOFs) and other functional materials. Additionally, hydrazine-based compounds have shown promise as intermediates in synthesizing pesticides and herbicides due to their reactivity with biological targets.

Regulatory considerations play a crucial role in the commercialization of 3-(Pyrrolidine-1-sulfonyl)benzohydrazide. Compliance with Good Manufacturing Practices (GMP) ensures that the compound meets stringent quality standards for pharmaceutical use. Furthermore, ongoing research into its toxicological profile is essential to assess its safety margins and potential side effects before clinical translation.

In conclusion, 3-(Pyrrolidine-1-sulfonyl)benzohydrazide (CAS No. 328028-06-4) represents a fascinating example of how structural complexity can be leveraged to develop novel bioactive molecules. Its unique combination of functional groups positions it as a versatile tool for researchers exploring new therapeutic strategies across multiple disciplines. As scientific understanding continues to evolve, this compound is likely to remain at the forefront of innovation in chemical biology and drug discovery.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)